Fermentalg: sales stability at the end of September 2025 and growth prospects

Fermentalg, a specialist in BioSolutions based on aquatic microorganisms, announces stable revenue of €9.6 million at the end of September 2025. The company maintains its target of double-digit annual growth, forecasting revenue of €13 million in 2025, compared to €11.5 million in 2024. Favorable outlook is confirmed for 2026 thanks to new products and expansion into new market segments.

The infant nutrition and aquaculture segments account for 40% of annual sales. The Ωrigins™ range, algae-derived DHA produced in Europe, is expanding into these markets in response to the demand for sustainability. Europe accounts for 80% of sales, but Fermentalg is preparing to expand with a recent agreement with the Chinese company SIRIO.

Fermentalg is also preparing to market its natural blue colorant, Galdieria Blue, in the United States. Production of the first industrial batches is underway to meet orders expected in 2026. This product could supplant existing synthetic colorants in the beverage and confectionery market.